Skip to main content

Commodore Capital LP

SEC CIK
0001831942
Latest filing
Aug 14, 2026

RXDX holding history

Prometheus Biosciences, Inc. in every 13F filed by Commodore Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXDX overviewAll 13F holders of RXDXFull Q2 2026 holdings

Shares (Q2 2023)
0
Sold out in Q2 2023
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q4 2022
Holdings of RXDX by Commodore Capital LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20230$00.0%−127,156−100.0%Sold outHolders
Q1 2023127,156$13.6M2.1%00.0%UnchangedHolders
Q4 2022127,156$14.0M2.1%+127,156NewHolders